Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-97-009182
Filing Date
1997-11-06
Accepted
1997-11-06 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORP
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SCHEULE 13D / CELL THERAPEUTICS, INC. SC 13D 29857
  Complete submission text file 0000950123-97-009182.txt   31692
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48459 | Film No.: 97708965
SIC: 2834 Pharmaceutical Preparations